Mallinckrodt plc Provides Update on Executive Committee

/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today provided an update on its...

Related Keywords

Dublin ,Ireland ,Steven Romano ,Aaron Palash ,Michael Freitag ,Hugh Oneill ,Jason Goodson ,Kassie Harrold ,Prnewswire Mallinckrodt ,Wilkinson Brimmer Katcher ,Ian Watkins ,Mark Tyndall ,Stephen Welch ,Joele Frank ,Siggi Olafsson ,Danielj Speciale ,Bryan Reasonswill ,Derek Belz ,Henriette Nielsen ,Mark Casey ,Mallinckrodt Pharmaceuticals ,Business Operations At Hikma Pharmaceuticals ,Exchange Commission ,Head Of Corporate Development ,Mallinckrodt Government Affairs ,Science Technology ,Company Environmental ,Company Specialty Brands ,Executive Committee ,Chief Executive Officer ,Chief Financial Officer ,Chief Transformation Officer ,Business Operations ,Chief Legal Officer ,Corporate Secretary ,Government Affairs ,Patient Advocacy ,Corporate Development ,Chief Compliance Officer ,Chief Compliance ,With Mallinckrodt ,Corporate Integrity Agreement ,Specialty Generics Operating ,General Manager ,Specialty Generics ,Chief Commercial ,Operations Officer ,Chief Scientific Officer ,Specialty Brands ,Investor Relations ,Private Securities Litigation Reform Act ,Annual Report ,Corporate Controller ,Chief Investor Relations ,Wilkinson Brimmer ,Mallinckrodt Plc ,